DPP4i vildagliptin reduces hippocampal FOXO1 and TNF-α levels in AD-PreDM mice [225] and decreases MDA levels, preventing lipid peroxidation, in AD-T2D mice [228]. The gene discussed is FOXO1; the disease is Alzheimer disease.